China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)

CompletedOBSERVATIONAL
Enrollment

887

Participants

Timeline

Start Date

March 18, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Ryzodeg®

Patients will be treated with commercially available Ryzodeg® in a prefilled device (FlexTouch®) or in a penfill according to the label and routine clinical practice at the discretion of the treating physician

Trial Locations (50)

37000

NIS-The First People's Hospital of Yulin City, Yulin

100005

NIS-Beijing Hospital, Beijing

100050

NIS-Beijing Friendship Hospital, Capital Medical University, Beijing

110032

NIS-The Fourth Hospital of China Medical University, Shenyang

116033

NIS-The Third People's Hospital of Dalian, Dalian

121012

NIS-Third Affiliated Hospital of Jinzhou Medical University, Jinzhou

125000

NIS-Huludao Central Hospital, Huludao

132013

NIS-Affiliated Hospital of Jilin Medical College, Jilin

138000

NIS-Songyuan Jilin Oilfield Hospital, Songyuan

150036

NIS-Heilongjiang Provincial Hospital, Harbin

200433

NIS-Shanghai Shidong Hospital, Shanghai

201203

NIS-Shanghai Shuguang Hospital, Shanghai

211199

NIS-Nanjing Jiangning Hospital, Nanjing

214200

NIS-Yixing City People's Hospital, Yixing

215501

NIS-Changshu Second People's Hospital, Changshu

223300

NIS-Huai'an First People's Hospital, Huai'an

226006

NIS-Nantong University - Affiliated Hospital, Nantong

230012

NIS-The Second People's Hospital of Hefei, Hefei

255036

NIS-Central hospital of zibo, Zhibo

256699

NIS-Binzhou Medical University-Yantai Affiliated Hospital, Yantai

261035

NIS-Weifang Medical University - Affiliated Hospital, Weifang

300070

NIS-Metabolic Diseases Hosp&Tianjin Institute of Endocrinolo, Tianjin

300190

NIS-Tianjin First Center Hospital, Tianjin

310014

NIS-Zhejiang Provincial People's Hospital, Hangzhou

312030

NIS-Shaoxing Central Hospital, Shaoxing

320100

NIS-Jiangsu Province Officeial Hospital, Nanjing

400320

NIS-People's Hospital of Chongqing Banan District, Chongqing

410013

NIS-The Third Xiangya Hospital of Central South University, Changsha

430000

NIS-Puai Hospital of Wuhan, Wuhan

442099

NIS-Shiyan City People's Hospital, Shiyan

450014

NIS-Zhengzhou University - The Second Affiliated Hospital, Zhengzhou

515041

NIS-2nd Affiliated Hospital of Shantou University Medical, Shantou

518172

NIS-Shenzhen Longgang District People's Hospital, Shenzhen

529020

NIS-The people's hospital of JiangMen, Jiangmen

529500

NIS-Yangjiang People's Hospital, Yangjiang

570203

NIS-Hainan Provincial Hospital of TCM, Haikou

637000

NIS-Affiliated Hospital of North Sichuan Medical College, Nanchong

655099

NIS-The First People's Hospital of Qujing, Qujing

678400

NIS-De Hong Zhou People's Hospital, Mang City

710018

NIS-Xi'an No.3 Hospital, Xi'an

723000

NIS-Hanzhong Central Hospital, Hanzhong

730000

NIS-Gansu Provincial People's Hospital, Lanzhou

750021

NIS-The People's Hospital of Ningxia Hui Autonomous Region, Yinchuan

810099

NIS- Qinghai Red Cross Hospital, Xining

061013

NIS-Cangzhou Hosp of Integrated Traditional Chinese Medicine, Cangzhou

056002

NIS-The First Hospital of Handan, Handan

066000

NIS-The First Hospital of Qinhuangdao, Qinhuangdao

024099

NIS-The Sceond Hospital of Chifeng, Chifeng

028000

NIS-Inner Mongolia University for Nationalities - Affiliated, Tongliao

030032

NIS-Shanxi Bethune Hospital, Taiyuan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT05221580 - China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE) | Biotech Hunter | Biotech Hunter